Nippon Shinyaku Co Ltd

Overview

Nippon Shinyaku Co Ltd (Nippon Shinyaku) develops, manufactures and sells ethical pharmaceuticals and functional foods. The company offers a wide range of products including drugs for pain, inflammation, and allergies; urological diseases; hematologic malignancies; gastrointestinal disorders; cardiovascular and metabolic diseases among others. Nippon Shinyaku also provides functional food ingredients including health food ingredients, preservatives, spices and condiments, and protein preparations. Its functional food products find application in meat processing, fish processing, dairy product, prepared food, confectionery and bakery, and beverage, among others. The company operates business through a network of offices and research laboratories located in Japan, China, the UK and the US. Nippon Shinyaku is headquartered in Minami-ku, Kyoto, Japan.
Key Stats
Address
14, Nishinosho Monguchi-cho, , Kisshoin, Minami-ku, Kisshoin, Minami-ku, KYOTO-SHI, Kyoto
Headquarters

Japan

Contact

81 75 3211111

No of Employees

2,059

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

4516 [TYO]

Revenue (2021)

$1,150 m

4.5% (2021 vs 2020)
Net Income (2021)

$195 m

22.6% (2021 vs 2020)
Net Profit Margin

17 %

17.5% (2021 vs 2020)
Market Cap *

$6,025 m

EPS *

$2.9

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Nippon Shinyaku Co LtdAstellas Pharma IncKyowa Kirin Co LtdShionogi & Co Ltd
Key Information
Headquarters Japan Japan Japan Japan
Headquarter City KYOTO-SHI CHUO-KU CHIYODA-KU OSAKA-SHI
Headquarter State/Province Kyoto Tokyo Tokyo Osaka
No. of Employees 2,059 15,455 5,423 5,485
Entity Type Public Public Public Public

Products & Services

Nippon is a Japan based pharmaceutical company. The company’s key product categories, pipeline candidates and brands include the following:

Products
  • Product Categories:
  • Urological drugs
  • Gastrointestinal drugs
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • API Chemical
  • Commercial Dose- Injectables
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
Brands
  • Eviprostat
  • Gaslon N
  • Hypen
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Shigenobu Maekawa Chairman Executive Board 2021 - Mr. Maekawa has been the Chairman of the company since 2021. Prior to this role, he served as President and...
Hiromu Nakajima Chief Medical Officer Senior Management - - Mr. Hiromu Nakajima serves as the Chief Medical Officer of the company.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 New Products/Services In March, the company received marketing authorization holder of Vidaza 100mg injection in Japan for…
2020 Acquisitions/Mergers/Takeovers In April, the company acquired Japan Marketing authorization of Tadalafil products from Eli Lilly Japan.
2020 Contracts/Agreements In February, the company entered into a new co-promotion agreement with Janssen Pharmaceuticals for ZYTIGA…
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


NS Pharma Inc

Address

Suite 280S, 140 East Ridgewood Avenue, Paramus
United States of America

Telephone

1 833 6778778

Website

www.nspharma.com
Sioe Pharmaceutical Co Ltd

Address

3-1-11 Shioe, Amagasaki
Japan

Telephone

81 6 64992601

Tajima Shokuhin Kogyo Co., Ltd.

Address

435, Higashishiba, Hidaka-cho, Toyooka, Hyogo
Japan

Telephone

81 796 421095

NS Shared Service Co Ltd

Address

14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto
Japan

Telephone

81 75 3148258

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
18 Mar 2021 Nippon Shinyaku Enters into Licensing Agreement with Menarini Licensing Agreement Nippon Shinyaku Co Ltd A. Menarini Industrie Farmaceutiche Riunite Srl
12 Aug 2020 Nippon Shinyaku Enters Manufacturing Agreement with Fuji Yakuhin for Viltepso Contract Service Agreement Nippon Shinyaku Co Ltd Fuji Yakuhin Co Ltd
12 Aug 2020 Nippon Shinyaku Enters API Manufacturing Agreement with Ajinomoto for Viltepso Contract Service Agreement Nippon Shinyaku Co Ltd Ajinomoto Co Inc
12 Aug 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
07 Feb 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
10 May 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

10

Active Jobs

0

Posted

0

Closed

Job Trends

Latest Jobs

Job title Company Country
Production engineering job Nippon Shinyaku Co Ltd China
Corporate staff position Nippon Shinyaku Co Ltd China
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar